Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Home CompaniesNyxoah

Nyxoah

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
0.9301 USD 0.02 ( 2.12%)
Last update at 2026-10-28T15:12:00Z
VOLUME
144281
Market Cap
251.23M

Momentum Score

…

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.92
Low
0.97
High
52 Week Price Range
4.00
Low
20.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.91
Dividend Yield
-
Revenue TTM
5.13M
Revenue Per Share
0.18
Gross Profit TTM
1.93M
Debt / Equity
0.13
ROE
-40.72%
Net Debt
-8.91M
ROCE
-29.60%
Diluted EPS TTM
-1.62

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -30.06M -24.64M -12.15M -7.18M -9.04M
Net income -31.23M -27.62M -12.24M -7.25M -9.08M
Selling general administrative 17.94M 11.11M 11.35M 5.37M 4.35M
Selling and marketing expenses 0.91M - - - -
Gross profit 1.93M 0.55M 0.04M -0.85M -2.52M
Reconciled depreciation 1.93M 1.66M 0.62M 0.43M 0.10M
Ebit -32.50M -26.24M -11.22M -6.52M -8.93M
Ebitda -25.74M -22.57M -11.37M -6.65M -8.84M
Depreciation and amortization 6.76M 3.67M -0.15M -0.13M 0.10M
Operating income -32.50M -26.24M -11.22M -6.52M -8.45M
Other operating expenses 35.58M 27.09M 11.29M 6.52M 8.45M
Interest expense 4.32M 2.07M 0.20M 0.05M 0.03M
Tax provision 1.17M 2.98M 0.09M 0.07M 0.04M
Interest income 6.76M 0.00M 0.00M 0.01M 0.00M
Net interest income 2.44M -1.60M -0.97M -0.62M -0.51M
Income tax expense 1.17M 2.98M 0.09M 0.07M 0.04M
Total revenue 3.08M 0.85M 0.07M 0.00M 0.00M
Total operating expenses 34.43M 26.79M 11.26M 6.52M 8.45M
Cost of revenue 1.15M 0.30M 0.03M 0.85M 2.52M
Total other income expense net 2.44M 1.60M -0.93M -0.67M -0.08M
Net income from continuing ops -31.23M -27.62M -12.24M -7.25M -9.08M
Net income applicable to common shares -31.23M -27.62M -12.24M -3.82M -9.08M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 124.16M 146.07M 170.83M 114.08M 15.20M
Intangible assets 46.61M 39.97M 25.32M 15.85M 5.73M
Other current assets 1.32M 1.28M 1.69M 0.11M 2.12M
Total liab 26.05M 25.75M 22.21M 16.89M 11.48M
Total stockholder equity 98.11M 120.32M 148.62M 97.19M 3.71M
Deferred long term liab - - 24.77M 15.26M 5.40M
Other current liab 5.00M 8.82M 0.65M 4.50M 1.68M
Common stock 4.93M 4.44M 4.43M 3.80M 2.48M
Capital stock 4.93M 4.44M 4.43M 3.80M 2.48M
Retained earnings -160.83M -118.21M -87.17M -60.34M -47.06M
Other liab - 0.06M 0.10M 0.04M 0.58M
Other assets - - 24.98M 15.38M 5.50M
Cash 21.61M 17.89M 135.51M 92.30M 5.86M
Total current liabilities 14.35M 14.91M 11.57M 6.40M 3.57M
Current deferred revenue 1.99M - 5.79M - -
Net debt -8.91M -6.01M -123.83M -80.76M 2.74M
Short term debt 1.22M 1.11M 1.14M 1.09M 0.72M
Short long term debt 0.36M 0.39M 0.55M 0.62M 0.38M
Short long term debt total 12.70M 11.88M 11.68M 11.54M 8.60M
Other stockholder equity 246.13M 233.92M 231.16M 153.59M 48.09M
Property plant equipment - 5.62M 5.24M 4.00M 1.39M
Total current assets 68.35M 100.26M 140.06M 94.11M 7.97M
Net tangible assets - - 148.07M 96.60M 0.67M
Short term investments 36.14M 76.97M - - -
Net receivables 5.97M 3.24M 2.51M 1.64M 2.11M
Long term debt 8.37M 8.19M 7.80M 7.61M 7.15M
Inventory 3.31M 0.88M 0.35M 0.06M -
Accounts payable 6.16M 4.99M 4.00M 0.81M 1.17M
Accumulated other comprehensive income 7.89M 0.18M 0.20M 0.15M 0.21M
Non currrent assets other 46.61M 0.17M 0.16M -0.00M 0.08M
Non current assets total 55.81M 45.81M 30.77M 19.97M 7.22M
Capital lease obligations 3.97M 3.31M 3.32M 3.32M 1.07M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -89.95M -11.82M -10.69M -5.79M -0.07M
Change to liabilities 0.00M 1.67M 1.11M 2.34M 0.36M
Total cashflows from investing activities - -11.82M -10.69M -5.79M -0.07M
Net borrowings - -0.86M 0.59M 0.73M 0.73M
Total cash from financing activities -0.98M 76.47M 104.18M 0.73M 15.00M
Net income -30.06M -24.64M -12.15M -7.18M -9.04M
Change in cash -117.62M 43.21M 86.44M -10.95M 6.70M
Begin period cash flow 135.51M 92.30M 5.86M 16.80M 10.11M
End period cash flow 17.89M 135.51M 92.30M 5.86M 16.80M
Total cash from operating activities -28.76M -25.34M -7.01M -5.96M -8.14M
Issuance of capital stock 0.26M 77.73M 103.58M 0.00M 15.00M
Depreciation 1.93M 1.66M 0.62M 0.43M 0.10M
Other cashflows from investing activities - - -0.01M -0.01M 0.00M
Dividends paid 0.00M 0.00M - - -
Change to inventory -0.54M -0.29M -0.06M -0.06M -0.06M
Change to account receivables - -2.52M 0.36M -1.39M -0.15M
Other cashflows from financing activities -0.17M -0.39M 1.19M 1.20M 0.23M
Change to netincome - 1.76M 3.19M 1.10M 0.64M
Capital expenditures 16.35M 11.82M 10.68M 5.79M 0.08M
Change in working capital 0.09M -1.14M 1.42M -0.24M 0.20M
Stock based compensation 2.70M 1.27M 2.55M 0.35M 0.03M
Other non cash items -3.42M -2.20M 0.79M 0.74M 0.65M
Free cash flow -45.10M -37.15M -17.70M -11.75M -8.22M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NYXH
Nyxoah		 0.02
2.12%		 0.93 - - 63.63 2.46 56.11 -5.80
ISRG
Intuitive Surgical Inc		 1.84
0.41%		 447.73 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme		 -3.50
1.72%		 200.50 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -2.19
2.16%		 99.02 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 0.60
0.31%		 195.63 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Rue Edouard Belin 12, Mont-Saint-Guibert, Belgium, 1435

32 10 22 23 55

https://www.nyxoah.com

146

Name Title Year Born
Mr. Robert Taub MBA Co-Founder & Chairman 1947
Mr. Olivier Taelman CEO & Exec. Director 1972
Mr. Loic Moreau Chief Financial Officer 1980
Ms. Dorit Nahari VP of Operations NA
Mr. Bruno Onkelinx Chief Technology Officer NA
Mr. Jeremy Feffer VP of Investor Relations & Corp. Communication NA
Ms. An Moonen Gen. Counsel NA
Mr. Olivier Taelman CEO & Executive Director 1972
Mr. Loic Moreau Chief Financial Officer 1981
Mikaela Kirkwood Corporate Communication & Investor Relations Manager NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

BRAI
USD 4.72
+42.60%
GMAB
USD 56.95
+27.48%
AXGN
USD 47.46
+26.70%
ROMA
USD 5.60
+19.40%
KIDS
USD 28.25
+18.62%
BCAX
USD 10.53
-39.76%
OTLY
USD 8.17
-30.47%
AXG
USD 0.03
-24.25%
PARA
USD 3.34
-23.74%
GERN
USD 0.89
-22.73%

Equity Sectors*

  • Basic Materials

    -0.54%

  • Communication Services

    -0.68%

  • Consumer Cyclical

    -0.20%

  • Consumer Defensive

    -0.36%

  • Energy

    +0.17%

  • Financial Services

    -0.33%

  • Financials

    -0.88%

  • Healthcare

    +0.66%

  • Industrials

    -0.08%

  • Real Estate

    -0.29%

  • Technology

    -0.06%

  • Utilities

    -0.13%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…